Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]

Additional Metadata
Persistent URL	doi.org/10.1016/j.clim.2013.11.001, hdl.handle.net/1765/52421
Journal	Clinical Immunology
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Allard, S. D., de Keersmaecker, B., de Goede, A., Verschuren, E., Koetsveld, J., Reedijk, M., … Gruters, R. (2014). Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]. Clinical Immunology, 150(1), 88–89. doi:10.1016/j.clim.2013.11.001

Publication